SunOpta (NASDAQ:STKL) Upgraded at StockNews.com

by · The Cerbat Gem

StockNews.com upgraded shares of SunOpta (NASDAQ:STKL – Free Report) (TSE:SOY) from a sell rating to a hold rating in a research report report published on Tuesday.

Separately, Stephens restated an “overweight” rating and set a $10.00 target price on shares of SunOpta in a research note on Thursday, January 2nd.

Get Our Latest Analysis on SunOpta

SunOpta Stock Down 6.2 %

STKL stock opened at $5.32 on Tuesday. The firm has a 50 day moving average of $7.03 and a 200 day moving average of $6.94. The stock has a market capitalization of $637.01 million, a PE ratio of -29.55 and a beta of 1.90. The company has a quick ratio of 0.53, a current ratio of 1.20 and a debt-to-equity ratio of 1.61. SunOpta has a 52 week low of $4.88 and a 52 week high of $8.11.

SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) last posted its earnings results on Wednesday, February 26th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. The firm had revenue of $193.91 million during the quarter, compared to analyst estimates of $189.90 million. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%. Sell-side analysts forecast that SunOpta will post 0.13 earnings per share for the current year.

Insider Activity

In other news, SVP Bryan P. Clark sold 8,500 shares of SunOpta stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the transaction, the senior vice president now directly owns 28,150 shares of the company’s stock, valued at $149,758. The trade was a 23.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 6.48% of the company’s stock.

Institutional Investors Weigh In On SunOpta

Hedge funds have recently modified their holdings of the stock. Bayesian Capital Management LP boosted its position in SunOpta by 15.2% during the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company’s stock valued at $89,000 after purchasing an additional 1,523 shares during the period. Ironwood Investment Management LLC raised its stake in shares of SunOpta by 1.2% in the 4th quarter. Ironwood Investment Management LLC now owns 132,879 shares of the company’s stock worth $1,023,000 after buying an additional 1,549 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of SunOpta by 15.2% in the 4th quarter. Quadrant Capital Group LLC now owns 14,542 shares of the company’s stock worth $112,000 after buying an additional 1,923 shares in the last quarter. EP Wealth Advisors LLC raised its stake in shares of SunOpta by 18.7% in the 4th quarter. EP Wealth Advisors LLC now owns 14,730 shares of the company’s stock worth $113,000 after buying an additional 2,316 shares in the last quarter. Finally, Creative Planning raised its position in shares of SunOpta by 9.3% during the third quarter. Creative Planning now owns 30,716 shares of the company’s stock worth $196,000 after purchasing an additional 2,617 shares during the period. 85.39% of the stock is currently owned by hedge funds and other institutional investors.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Featured Articles